Simple Peptide TB-500 is a research-grade peptide sold for lab use only. Learn about purity, COAs, storage, and why it is not FDA-approved for humans.
Simple Peptide TB-500 is a research-grade peptide sold by the vendor Simple Peptide for laboratory use only. It is a synthetic fragment of the naturally occurring protein thymosin beta-4, and it is not approved by the FDA for human use. Researchers buy it to study cell migration, actin regulation, and tissue repair pathways in controlled experiments.
What Is Simple Peptide TB-500?
TB-500 is a synthetic analog of thymosin beta-4, a protein found in most human cells. The peptide is typically supplied as a lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before use in laboratory settings.
Simple Peptide sells TB-500 as a research chemical, not as a supplement or drug. Products are labeled “not for human consumption” and are intended for in vitro or animal research only. Every batch should come with a certificate of analysis (COA) that confirms identity, purity, and concentration.
TB-500 is often discussed alongside BPC-157 because both peptides are studied in preclinical models of tissue repair. However, they are chemically distinct and work through different mechanisms.
How TB-500 Works in Research Settings
In laboratory studies, TB-500 is investigated for its ability to bind actin, a protein that forms the cell cytoskeleton. By sequestering actin, the peptide may influence cell migration, proliferation, and differentiation.
Preclinical research has explored TB-500 in models of:
- Wound healing and soft tissue repair
- Inflammation reduction
- Angiogenesis (new blood vessel formation)
- Joint flexibility and tendon recovery
These studies are almost entirely in animals or cell cultures. No large-scale human trials have established safety or efficacy. As a result, any claim that TB-500 treats a specific condition in humans is not supported by regulatory evidence.
TB-500 and BPC-157 are frequently studied in parallel, but researchers should treat each compound as a separate variable.
Simple Peptide TB-500 vs. BPC-157: A Comparison
Researchers often compare TB-500 and BPC-157 because both are marketed for recovery-related research. The table below summarizes key differences.
| Feature | TB-500 | BPC-157 |
|---|---|---|
| Origin | Synthetic fragment of thymosin beta-4 | Synthetic pentadecapeptide derived from gastric juice |
| Primary research mechanism | Actin binding, cell migration | Angiogenesis, growth factor upregulation |
| Reported half-life | Not well established in humans | Roughly 4 hours in some animal models |
| Common research focus | Soft tissue repair, inflammation, flexibility | Gut lining, tendon, ligament, joint studies |
| FDA approval for humans | Not approved | Not approved |
Many researchers also search for simple peptide bpc 157 tb 500 when they want to source both peptides from the same vendor. Buying from a single supplier can simplify COA tracking, but it does not guarantee quality.
Buying TB-500: Vendor and Quality Checks
If you are looking for where to buy bpc-157 and tb-500, prioritize vendors that publish third-party certificates of analysis for every lot. A COA should include high-performance liquid chromatography (HPLC) and mass spectrometry results.
Before ordering, read simple peptide com reviews to gauge other researchers' experiences with purity, shipping, and customer service. Independent forums and review sites often provide more candid feedback than vendor websites.
What to Look for in a COA
- Peptide purity above 98% (ideally 99%)
- Lot number that matches the product label
- Testing date within the last 12 months
- Third-party laboratory name and contact information
Storage and Reconstitution
Lyophilized TB-500 should be stored at -20°C or colder, protected from light. After reconstitution with bacteriostatic water, most vendors recommend refrigerating at 2–8°C and using within a few weeks. Avoid repeated freeze-thaw cycles, which can degrade the peptide.
Safety, Side Effects, and Legal Status
TB-500 is not FDA-approved for human use in the United States. It is sold strictly for research purposes, and possessing it for personal use may violate local laws or regulations.
Preclinical studies report few tb-500 side effects, but human safety data are lacking. Potential risks observed in animal models include injection site reactions and immune responses. No long-term toxicity studies exist in humans.
Searches for bpc-157 and tb-500 dosage for injury reflect interest in recovery protocols, but no standardized human dosage exists. Any dosage information found online is based on animal research and should not be applied to humans.
If you are considering using TB-500 or any research peptide, consult a licensed healthcare professional. Self-administration of unapproved substances can lead to serious health consequences.
RELATED PEPTIDE TOPICTB-500 researchFrequently Asked Questions
Is Simple Peptide TB-500 safe for human use?
No. Simple Peptide TB-500 is sold for research purposes only and is not FDA-approved for human use. There are no large-scale human trials confirming its safety or effectiveness. Anyone considering it should consult a licensed healthcare professional.
Where can I read simple peptide com reviews?
Simple Peptide reviews can be found on independent forums, Reddit communities, and third-party peptide review sites. Focus on feedback about COA transparency, purity test results, and shipping reliability. Be cautious of reviews hosted directly on vendor websites.
What is the difference between TB-500 and BPC-157?
TB-500 is a synthetic fragment of thymosin beta-4 and is studied for actin regulation and cell migration. BPC-157 is a synthetic pentadecapeptide derived from gastric juice and is studied for angiogenesis and gut repair. Neither peptide is approved by the FDA for human use.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.